Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

JNJ US Equity

Johnson & JohnsonHealth Care · Pharmaceutical Preparations · CIK 200406 · FY ends Jan 3
$273.41
+2.30 (+0.85%)
USD · as of 2026-08-19 · marketstack
9 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-298-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-158-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-0113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-278-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-04-148-K 8.01Other eventssec.gov ↗
2026-04-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-01-218-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-148-K 8.01Other eventssec.gov ↗
2025-10-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-09-088-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-08

Every row is a filed document, checked against its EDGAR index.